129 related articles for article (PubMed ID: 10930690)
1. Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung.
Thomas LD; Dunkley ML; Moore R; Reynolds S; Bastin DA; Kyd JM; Cripps AW
Vaccine; 2000 Sep; 19(2-3):348-57. PubMed ID: 10930690
[TBL] [Abstract][Full Text] [Related]
2. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model.
Kyd JM; Dunkley ML; Cripps AW
Infect Immun; 1995 Aug; 63(8):2931-40. PubMed ID: 7622215
[TBL] [Abstract][Full Text] [Related]
3. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.
Cripps AW; Dunkley ML; Clancy RL
Infect Immun; 1994 Apr; 62(4):1427-36. PubMed ID: 8132349
[TBL] [Abstract][Full Text] [Related]
4. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
Gomi R; Sharma A; Wu W; Sung B; Worgall S
Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
[TBL] [Abstract][Full Text] [Related]
5. Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa.
Thomas LD; Kyd JM; Bastin DA; Dunkley ML; Cripps AW
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):155-60. PubMed ID: 12832119
[TBL] [Abstract][Full Text] [Related]
6. Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection.
Moore R; Kyd JM; Carzino R; Armstrong D; Grimwood K; Otczyk DC; Cripps AW
Hum Vaccin Immunother; 2013 Mar; 9(3):506-14. PubMed ID: 23249482
[TBL] [Abstract][Full Text] [Related]
7. Immune response mechanisms against Pseudomonas aeruginosa associated with mucosal immunization with protein antigens in a rat model of acute lung infection.
Thomas LD; Cripps AW; Kyd JM
Vaccine; 2009 May; 27(25-26):3324-30. PubMed ID: 19200832
[TBL] [Abstract][Full Text] [Related]
8. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
9. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.
Thakur A; Kyd J; Xue M; Willcox MD; Cripps A
Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752
[TBL] [Abstract][Full Text] [Related]
10. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
[TBL] [Abstract][Full Text] [Related]
11. Investigation of mucosal immunisation in pulmonary clearance of Moraxella (Branhamella) catarrhalis.
Kyd J; John A; Cripps A; Murphy TF
Vaccine; 1999 Oct; 18(5-6):398-406. PubMed ID: 10519928
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
13. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection.
Ciofu O; Bagge N; Høiby N
APMIS; 2002 Dec; 110(12):881-91. PubMed ID: 12645667
[TBL] [Abstract][Full Text] [Related]
15. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
Baumann U; Göcke K; Gewecke B; Freihorst J; von Specht BU
Respir Res; 2007 Aug; 8(1):57. PubMed ID: 17683588
[TBL] [Abstract][Full Text] [Related]
16. [Local immunization against P. aeruginosa with an outer-membrane-protein vaccine].
Grundmann T; Freihorst J; Kubesch P; Tümmler B; von der Hardt H
Pneumologie; 1991 Nov; 45(11):924-7. PubMed ID: 1763004
[TBL] [Abstract][Full Text] [Related]
17. Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A.
Johansen HK; Cryz SJ; Høiby N
APMIS; 1994 Jul; 102(7):545-53. PubMed ID: 7917224
[TBL] [Abstract][Full Text] [Related]
18. Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection.
Johansen HK; Espersen F; Cryz SJ; Hougen HP; Fomsgaard A; Rygaard J; Høiby N
Infect Immun; 1994 Aug; 62(8):3146-55. PubMed ID: 8039883
[TBL] [Abstract][Full Text] [Related]
19. Experimental immunization with Pseudomonas aeruginosa alginate induces IgA and IgG antibody responses.
Johansen HK; Høiby N; Pedersen SS
APMIS; 1991 Dec; 99(12):1061-8. PubMed ID: 1772641
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat.
Dunkley ML; Rajyaguru S; McCue A; Cripps AW; Kyd JM
FEMS Immunol Med Microbiol; 2003 Oct; 39(1):37-44. PubMed ID: 14556994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
